Lakefront Biotherapeutics NV (LKFT34.SA) Q3 2026 Earnings

10AugConfirmed
Q2 2026
Next
-4.65
-2.7
-0.75
1.2

Details

Expected EPS
-4.135102083196927
Actual EPS
N/A
Surprise EPS
4.14
Surprise Percent
+100%

Description

Lakefront Biotherapeutics NV (LKFT34.SA) will report earnings of for Q3 2026 on August 10, 2026.

0 Comments

Share your thoughts